<?xml version="1.0" encoding="utf-8"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Old Tom</title><link>https://investorshangout.com/profile/view?id=13142</link><description><![CDATA[Old Tom]]></description><language>en-us</language><pubDate>Sun, 18 Oct 2026 23:42:36 GMT</pubDate><copyright>Copyright InvestorsHangout.com</copyright><atom:link href="https://investorshangout.com/profile/view?id=13142" rel="self" type="application/rss+xml"/><item><title>Old Tom: The best is still to come Recently, a GW</title><link>https://investorshangout.com/post/view?id=1604748</link><guid>https://investorshangout.com/post/view?id=1604748</guid><description><![CDATA[Old Tom
]]></description><pubDate>Sun, 22 Jun 2014 20:53:23 GMT</pubDate></item><item><title>Old Tom: Acadia&#039;s lauroxil vs Lundbeck&#039;s Maintena</title><link>https://investorshangout.com/post/view?id=1604742</link><guid>https://investorshangout.com/post/view?id=1604742</guid><description><![CDATA[Old Tom
]]></description><pubDate>Sun, 22 Jun 2014 20:33:44 GMT</pubDate></item></channel></rss>